Pharmascience Inc. has launched Prpms-NITROFURANTOIN (nitrofurantoin monohydrate / macrocrystals capsules) in Canada for the treatment of urinary tract infections. “With the launch of Prpms-NITROFURANTOIN, manufactured in Canada, we become the first generic bioequivalent to MacroBID on the Canadian market,” said Jean-Guy Goulet, chief operating officer at Pharmascience Inc. Prpms-NITROFURANTOIN is indicated for the treatment of patients suffering from…